HIV Scientific Papers
Long-acting ibalizumab susceptibility in multi-drug resistant HIV patients [abstract].
2017
Weinheimer S, Marsolais C, Cohen Z, Lewis S.
#MOPEB0352. Presented at: 9th IAS Conference on HIV Science; July 23-26 2017; Paris, France.
Long-acting ibalizumab susceptibility in multi-drug resistant HIV patients.
2017
Weinheimer S, Marsolais C, Cohen Z, Lewis S.
Poster #MOPEB0352 presented at: 9th IAS Conference on HIV Science; July 23-26 2017; Paris, France.
Long-acting ibalizumab in patients with multi-drug resistant HIV-1: a 24-week study [abstract].
2017
Top Antivir Med.
Lewis S, Fessel J, Emu B, et al.
"27(suppl 1):185s. Proceedings of the 2018 Conference on Retroviruses and Opportunistic Infections. "
Long-acting ibalizumab in patients with multi-drug resistant HIV-1: a 24-week study.
2017
Lewis S, Fessel J, Emu B, et al.
Poster #449LB presented at: Conference on Retroviruses and Opportunistic Infections; February 13-16, 2017; Seattle, Washington, USA.
Intramuscular ibalizumab: pharmacokinetics, safety, and efficacy vs IV administration [abstract].
2017
Lin H-H, Lee SS-J, Wang N-C, et al.
"27(suppl 1):180s. Proceedings of the 2018 Conference on Retroviruses and Opportunistic Infections. "